Opin vísindi

Fletta eftir efnisorði "Elimination"

Fletta eftir efnisorði "Elimination"

Röðun: Raða: Niðurstöður:

  • Thomadakis, Christos; Gountas, Ilias; Duffell, Erika; Gountas, Konstantinos; Bluemel, Benjamin; Seyler, Thomas; Pericoli, Filippo Maria; Kászoni-Rückerl, Irene; El-Khatib, Ziad; Busch, Martin; Schmutterer, Irene; Vanwolleghem, Thomas; Klamer, Sofieke; Plettinckx, Els; Mortgat, Laure; Van Beckhoven, Dominique; Varleva, Tonka; Kosanovic Licina, Mirjana Lana; Nemeth Blazic, Tatjana; Nonković, Diana; Theophanous, Fanitsa; Nemecek, Vratislav; Maly, Marek; Christensen, Peer Brehm; Cowan, Susan; Rüütel, Kristi; Brummer-Korvenkontio, Henrikki; Brouard, Cécile; Steffen, Gyde; Krings, Amrei; Dudareva, Sandra; Zimmermann, Ruth; Nikolopoulou, Georgia; Molnár, Zsuzsanna; Kozma, Emese; Gottfreðsson, Magnús; Murphy, Niamh; Kondili, Loreta A.; Tosti, Maria Elena; Ciccaglione, Anna Rita; Suligoi, Barbara; Nikiforova, Raina; Putnina, Renate; Jancoriene, Ligita; Seguin-Devaux, Carole; Melillo, Tanya; Boyd, Anders; van der Valk, Marc; Op de Coul, Eline; Whittaker, Robert; Kløvstad, Hilde; Stępień, Małgorzata; Rosińska, Magdalena; Valente, Cristina; Marinho, Rui Tato; Popovici, Odette; Avdičová, Mária; Kerlik, Jana; Klavs, Irena; Maticic, Mojca; Diaz, Asuncion; del Amo, Julia; Lundberg Ederth, Josefine; Axelsson, Maria; Nikolopoulos, Georgios (2024-01)
    Background: Epidemiological data are crucial to monitoring progress towards the 2030 Hepatitis C Virus (HCV) elimination targets. Our aim was to estimate the prevalence of chronic HCV infection (cHCV) in the European Union (EU)/European Economic Area ...
  • Ólafsson, Sigurður; Tyrfingsson, Þórarinn; Rúnarsdóttir, Valgerður; Bergmann, Óttar Már; Hansdóttir, Ingunn; Björnsson, Einar Stefán; Jóhannsson, B.; Sigurðardóttir, Bryndís; Fridriksdóttir, R. H.; Löve, Arthur; Hellard, M.; Löve, Þorvarður Jón; Gudnason, Thorarinn; Heimisdottir, María; Gottfredsson, Magnus (Wiley, 2018-03-07)
    A nationwide programme for the treatment of all patients infected with hepatitis C virus (HCV) was launched in Iceland in January 2016. By providing universal access to direct‐acting antiviral agents to the entire patient population, the two key aims ...